The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School
Clinical trials sponsored by The Affiliated Nanjing Drum Tower Hospital Of Nanjing University Medical School, explained in plain language.
-
Combination therapy aims to wipe out High-Risk prostate cancer before surgery
Disease control Not yet recruitingThis trial investigates whether combining a targeted radioactive drug (177Lu-PSMA-617) with a hormone therapy (darolutamide) before surgery can improve outcomes for men with high-risk localized prostate cancer. Participants receive two doses of the radioactive drug and daily horm…
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jul 02, 2026 01:00 UTC
-
Could a common diabetes drug boost heart pump recovery?
Disease control Not yet recruitingThis study tests whether metformin, a standard diabetes medicine, can improve heart function in people who have received a mechanical heart pump (LVAD) for severe heart failure. Researchers will give metformin or a placebo to 108 patients for 12 months and check heart function, b…
Phase: PHASE1, PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Psoriasis patients: does your injection schedule matter?
Disease control Not yet recruitingThis study looks at 120 adults with moderate-to-severe psoriasis who take secukinumab, a biologic drug. It compares two maintenance schedules: the standard every-4-week injection versus a non-standard schedule (longer intervals or lower dose). The goal is to see which schedule ke…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a zap to the ear boost memory in diabetes patients?
Disease control Not yet recruitingThis study tests whether a mild electrical stimulation applied to the ear (via a small device) can improve memory and thinking in people with type 2 diabetes who also have mild cognitive impairment. The trial will involve 38 participants who will either receive the active stimula…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New Blood-Filtering strategy aims to save lives from weed killer poisoning
Disease control Not yet recruitingThis early-stage trial tests whether starting a specific type of blood filtering (hemodiafiltration) immediately after a standard blood-cleaning treatment (hemoperfusion) can improve survival in people with severe diquat poisoning. Diquat is a herbicide that can cause rapid kidne…
Phase: PHASE1 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Virus cocktail takes on superbug UTIs in tiny new trial
Disease control Not yet recruitingThis early study tests whether a personalized mix of viruses (called phages) can safely treat urinary tract infections caused by drug-resistant bacteria. Six adults aged 18–65 will receive the phage cocktail through a catheter every 12 hours for 2–3 days. Researchers will monitor…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New stent device aims to better seal brain aneurysms
Disease control Not yet recruitingThis study compares a newer flow-diverting stent to standard stent-assisted coiling for treating unruptured brain aneurysms in the middle cerebral artery. About 140 adults aged 18-70 will be randomly assigned to one of the two procedures. The main goal is to see which method more…
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New snare technique may offer faster, safer tumor removal
Disease control Not yet recruitingThis study compares two ways to remove small rectal neuroendocrine tumors (less than 1 cm). The new method, called modified double snare EMR, is expected to be just as effective as the standard ESD procedure but with shorter operation time, fewer complications, and lower cost. Ab…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New trial matches liver cancer treatment to Tumor's Fat-Burning signature
Disease control Not yet recruitingThis phase II trial tests a personalized approach for people with advanced liver cancer that cannot be removed by surgery. Researchers will classify each patient's tumor by its fatty acid degradation (FAD) subtype and assign either a drug combination (camrelizumab plus apatinib) …
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for bladder cancer: drug combo aims to shrink tumors when first treatment fails
Disease control Not yet recruitingThis study tests a new combination of the drug entinostat plus standard chemotherapy for people with advanced bladder cancer that has spread or cannot be removed by surgery and has not responded to first-line treatment. About 29 participants will receive the combination to see if…
Phase: PHASE1, PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New triple attack on rare melanoma shows promise in early trial
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs (carilizumab and apatinib) plus radiation therapy as a first treatment for advanced mucosal melanoma, a rare and aggressive skin cancer. The study will enroll 30 adults who have not had prior systemic therapy. Researchers will m…
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could immune cells from your own body help you carry a baby?
Disease control Not yet recruitingThis study tests whether a woman's own immune cells, turned into decidual-like NK cells in a lab and then placed back into her uterus, can improve pregnancy chances. It includes 159 women with abnormal uterine NK cells and a history of reproductive failure. The main goal is to se…
Phase: PHASE2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Race against poison: can early dialysis beat the clock?
Disease control Not yet recruitingThis study compares two approaches to dialysis in people who have been severely poisoned by the herbicide diquat. One group starts dialysis right away after a blood-cleaning procedure, while the other waits until kidney damage appears. The goal is to see if earlier dialysis reduc…
Phase: PHASE3 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New blood test could speed up diquat poisoning diagnosis
Diagnosis Not yet recruitingThis study checks if a new portable device can accurately measure diquat (a toxic herbicide) in blood samples from 60 people with suspected poisoning. The goal is to see if the new method matches the standard lab test. If successful, it could help doctors diagnose poisoning faste…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Zapping the brain to restore hand movement after stroke
Symptom relief Not yet recruitingThis study tests whether a gentle electrical current applied to the brain (tDCS) combined with hand exercises can improve hand function in people who had a stroke. Fifty-six participants will receive either real or sham tDCS for 20 sessions over four weeks. Researchers will use M…
Phase: NA • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Fish oil may protect nerves during cancer treatment
Symptom relief Not yet recruitingThis study tests if taking fish oil by mouth can prevent or lessen nerve damage (peripheral neuropathy) caused by the chemotherapy drug bortezomib in people with multiple myeloma. Researchers will compare nerve health in 200 patients who take fish oil versus those who don't. The …
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
AI tool aims to spot head and neck cancer risk early
Knowledge-focused Not yet recruitingThis study will use artificial intelligence to create a risk prediction model for head and neck cancers, including cancers of the throat and voice box. Researchers will collect data from 3000 participants, including their medical history, lifestyle habits, and laryngoscopy images…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC